COMMUNIQUÉS West-GlobeNewswire

Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
30/01/2024
WARREN, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and [...]
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
30/01/2024
BOCA RATON, Fla. , Jan. 30, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological [...]
INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program
30/01/2024
The Phase II clinical trial in patients with Alzheimer’s disease with neuroinflammation is on track to complete enrollment mid-2024 with top line data expected approximately six months after the final patient is [...]
Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation
30/01/2024
FORT LAUDERDALE, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or “Motus GI” or “the Company”), a medical technology company focused on improving endoscopic outcomes and experiences, [...]
Aprea Therapeutics to Present at DDR Inhibitors Summit 2024
30/01/2024
DOYLESTOWN, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic [...]
Central California’s Community Regional Medical Center is the First in the State to Offer Next Generation Robotic Bronchoscopy for Early Diagnosis and Treatment of Lung Cancer
30/01/2024
Innovative new Galaxy System™ deployed as part of commitment to improving the health of residents in the central San Joaquin Valley FRESNO, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- As part of its mission to better the [...]
NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note
30/01/2024
DURHAM, N.C., Jan. 30, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) (“NightHawk” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced it [...]
Accompany Health Launches to Care for Low-Income Patients with Complex Needs
30/01/2024
New Company Raises $56 Million Series A Funding Round BETHESDA, Md., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Accompany Health , a primary, behavioral, and social care provider for low-income patients with complex needs, [...]
MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene
30/01/2024
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, [...]
Immutep Quarterly Activities Report Q2 FY24
30/01/2024
Media Release Excellent clinical data reported from TACTI-002 Phase II trial, including median Overall Survival of 35.5 months in first line non-small cell lung cancer (1L NSCLC) patients expressing PD-L1 (TPS ≥1%) [...]
Tome Biosciences Appoints Industry Veteran Daniel Curran, MD, to its Board of Directors
30/01/2024
WATERTOWN, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Tome Biosciences, Inc., the programmable genomic integration (PGI) company, announces the appointment of Daniel Curran, MD, to its Board of Directors. Dr. Curran was [...]
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
30/01/2024
PLEASANTON, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today that the United States Food and Drug [...]
iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member
30/01/2024
Mr. Doyle offers extensive experience in AI enabled healthcare platforms and global business strategy. NASHUA, N.H., Jan. 30, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI- [...]
Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS
30/01/2024
Over 2,100 registrants with attendees from 92 countries Average daily attendance of 574 32 oral presentations delivered across four consecutive days 69 scientific posters featuring optical genome mapping (OGM) on view [...]
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
30/01/2024
Garden City, NY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics, therapeutics and diagnostics company, today reported that Jason [...]
Spectral Medical Provides January Tigris Trial Update
30/01/2024
85 patients enrolled TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock [...]
Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil
30/01/2024
The first THC containing pharmaceutical preparations produced in Brazil approved by the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria, “ANVISA”) TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- [...]
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
30/01/2024
All of the cash payable to the plaintiffs in the settlement will be covered by Microbot’s insurance carrier and will not impact company's cash position BRAINTREE, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Microbot [...]
VPR Brands Triumphs Again in PTAB Ruling, Upholding Key Electronic Cigarette Patent
30/01/2024
The Company's Robust Patent and Trademark Portfolio and Innovation in Vaping Technologies Make it a Key Player in Product Development for Vaping Technologies, Catering to Both Nicotine and Cannabis Markets FORT [...]

Pages